Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One power score. Smarter investment decisions
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Sign Up
Sign Up
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Krispy Kreme tumbles after wider-than-expected quarterly loss
** Shares of Krispy Kreme DNUT.O down 12% at $3 premarket** Posts Q2 loss of 15c/shr vs 3 c/shr analysts' estimate -data compiled by LSEG** DNUT takes $356 mln non-cash goodwill impairment charge from failed McDoanald's MCD.N partnership**In March, the company partnered with MCD to sell its ...
Reuters
Thu, Aug 7
Prospect of Trump-Putin meeting lifts Russia stocks, rouble, Ukraine bonds
LONDON, Aug 7 (Reuters) - Russia's rouble strengthened, Moscow stocks jumped and Ukrainian bonds rallied on Thursday after the prospect of a meeting between Russian President Vladimir Putin and U.S. President Donald Trump fuelled hopes of easing geopolitical tensions. Russia's main stock mar...
Reuters
Thu, Aug 7
Intel slips as Trump calls for CEO's resignation
** Shares of chipmaker Intel INTC.O fall 4% to $19.68 in premarket trading** U.S. President Donald Trump said "Intel CEO is highly conflicted and should resign immediately"** Yesterday, U.S. Republican Senator Tom Cotton sent a letter to Intel questioning about chipmaker's new CEO Lip-Bu...
Reuters
Thu, Aug 7
Vistra reports lower quarterly profit on higher operating and interest costs
Aug 7 (Reuters) - Vistra Corp VST.N reported a fall in second-quarter profit on Thursday, weighed on by higher operating and interest costs, sending its shares down about 6% in premarket trading.Continued higher-for-longer interest rates can weigh on utilities as it makes investing in the constructi...
Reuters
Thu, Aug 7
Crocs falls after casual footwear maker expects drop in third-quarter revenue
** Shares of casual footwear maker Crocs CROX.O down ~17% at $87.77 premarket** Co expects third-quarter revenue to be down about 9% to 11% compared to a 2% rise reported a year ago; analysts' expected a rise of 0.3%, as per data compiled by LSEG** Sees adjusted operating margin for third quarte...
Reuters
Thu, Aug 7
Global stocks rise on Ukraine ceasefire hopes, Fed cut bets; pound rises after BoE
LONDON, Aug 7 (Reuters) - Global equities rose on Thursday, with Japanese shares hitting a record high, as upbeat earnings, growing hopes for a ceasefire in Ukraine and expectations for U.S. rate cuts boosted sentiment.
Reuters
Thu, Aug 7
Ormat (ORA) Q2 Revenue Jumps 10%
Key PointsAdjusted diluted earnings per share for Q2 2025 exceeded expectations at $0.48, topping estimates by 17%.Revenue (GAAP) for Q2 2025 rose 9.9% year over year to $234.0 million, exceeding analyst estimates by 5.6%.Product and Energy Storage segment gross margins improved sharply in Q2 2025, ...
The Motley Fool
Thu, Aug 7
Becton Dickinson rises after lifting annual profit forecast
** Medical device maker Becton Dickinson's BDX.N shares gain 5.9% to $182.50 premarket** BDX now expects its 2025 adjusted profit per share between $14.30 and $14.45, compared with its prior range of $14.06 to $14.34** It reaffirms its annual revenue to be between $21.8 billion and $21.9 billion...
Reuters
Thu, Aug 7
Peloton rises after posting upbeat quarterly results
** Fitness products maker Peloton Interactive PTON.O shares rise 10.5% to $7.81 premarket after reporting Q4, FY25 results** Co reports Q4 revenue and profit above Wall Street estimates** Q4 revenue of $606.9 mln, beats est. of $579.78 mln - LSEG ** Reports Q4 profit of 5 cents per share above...
Reuters
Thu, Aug 7
Us Foods (USFD) Q2 EPS Jumps 28%
Key PointsAdjusted diluted EPS rose to $1.19, topping non-GAAP EPS estimates and marking 28.0% growth in Adjusted Diluted EPS from the year-ago quarter.Revenue (GAAP) reached $10.1 billion, up 3.8% year over year (GAAP)Management increased full-year FY2025 adjusted EPS and adjusted EBITDA growth gui...
The Motley Fool
Thu, Aug 7
Immunic (IMUX) Q2 Loss Widens 25%
Key PointsVidofludimus calcium achieved strong Phase 2 results in progressive multiple sclerosis, showing up to a 34.4% reduction in 24-week confirmed disability worsening events in the primary progressive MS subgroup without gadolinium-enhancing lesions at baseline, based on April 2025 data from th...
The Motley Fool
Thu, Aug 7
1 Auto Stock That Actually Stands to Benefit From Tariffs
Key PointsTariffs have largely been a negative impact for the automotive industry.Aptiv is benefitting from a pull-forward of vehicle demand and production.Automakers will increasingly look to suppliers like Aptiv to save costs on full solutions.These 10 stocks could mint the next wave of millionair...
The Motley Fool
Thu, Aug 7
Kontoor (KTB) Q2 EPS Jumps 23%
Key Points- Revenue (GAAP) reached $658 million in Q2 FY2025, outpacing analyst expectations by 3.8% (non-GAAP) and rising 8% year over year in Wrangler U.S. wholesale revenue.- Adjusted earnings per share came in at $1.21, a 23% increase from the prior year and 45.8% above estimates (non-GAAP).- Th...
The Motley Fool
Thu, Aug 7
After Soaring More Than 100% This Year, Is It Too Late to Invest in Joby Aviation Stock?
Key PointsJoby Aviation hopes to be able to transport passengers on its aircraft by next year. The aircraft maker has recently completed multiple piloted flights in Dubai.The stock's valuation looks pricey, with the market cap now north of $14 billion.These 10 stocks could mint the next wave of mill...
The Motley Fool
Thu, Aug 7
Novo Nordisk shares jump as Eli Lilly's weight-loss pill data disappoints
Aug 7 (Reuters) - Shares in Novo Nordisk NOVOb.CO rose 13.6% on Thursday after trial data from Eli Lilly's LLY.N experimental weight-loss pill fell short of expectations, boosting investor confidence in the Danish drugmaker's market-leading obesity treatment. The market had anticipated Eli L...
Reuters
Thu, Aug 7
Lilly falls after oral weight-loss drug data fails to impress
** Shares of drugmaker Eli Lilly LLY.N fall 10.6% to $666.25 premarket** LLY says its oral weight loss drug, orforglipron, helped patients lose 12.4% of their body weight on average when given the highest dose of 36 milligrams in a late-stage study** "We are disappointed in this data, and expec...
Reuters
Thu, Aug 7
US STOCKS-Tech shares lift Wall St futures on tariff exemption hopes
Futures up: Dow 0.56%, S&P 500 0.62%, Nasdaq 0.8% Apple surges as $100 bln manufacturing pledge eases tariff fearsEli Lilly falls after late-stage data for oral weight-loss drugInitial jobless claims data due at 8:30 a.m. ETBy Nikhil Sharma and Pranav Kashyap Aug 7 (Reuters) - U.S. stock inde...
Reuters
Thu, Aug 7
United Parks (PRKS) Q2 EPS Falls 19%
Key PointsGAAP earnings per share and revenue both missed Wall Street estimates, with EPS (GAAP) at $1.45 versus the consensus of $1.80.Attendance increased slightly year over year, but per guest spending and net income (GAAP) declined.These 10 stocks could mint the next wave of millionaires › Unite...
The Motley Fool
Thu, Aug 7
Enovis (ENOV) Q2 Revenue Rises 7%
Key PointsRevenue rose 7% year over year to $565 million on a GAAP basis in Q2 2025, exceeding consensus estimates by $10.9 million.Non-GAAP earnings per share reached $0.79, topping analyst estimates by $0.07 and rising 27.4% year over year.The Reconstructive segment led with 11% reported growth, w...
The Motley Fool
Thu, Aug 7
3 Growth ETFs to Buy With $500 and Hold Forever
Key PointsVanguard Growth ETF is a cost-effective, all-weather growth fund to own as a foundational investment.With the biggest growth stocks becoming crowded trades, Invesco's next-gen ETF is a good alternative.The iShares Russell 1000 Growth ETF offers investors some much-needed exposure to mid-ca...
The Motley Fool
Thu, Aug 7
1
...
665
666
667
667
/
4247
668
669
...
4247
next page
KeyAI
Please log in to use KeyAI
Log in
Sign Up